Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume 6, Issue 3, Pages 97-114
Publisher
SAGE Publications
Online
2015-04-14
DOI
10.1177/2040622315579059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression
- (2015) Robin Ortiz et al. JOURNAL OF AFFECTIVE DISORDERS
- Homocysteine and cognitive functions in bipolar depression
- (2015) Agnieszka Permoda-Osip et al. Psychiatria Polska
- Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds
- (2014) Mark J. Niciu et al. Annual Review of Pharmacology and Toxicology
- Oral ketamine augmentation for chronic suicidality in treatment-resistant depression
- (2014) Angelo De Gioannis et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks
- (2014) A Villaseñor et al. BRITISH JOURNAL OF PHARMACOLOGY
- EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
- (2014) Rebecca B. Price et al. DEPRESSION AND ANXIETY
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine
- (2014) Dawn F. Ionescu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
- (2014) Mark J. Niciu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
- (2014) Elizabeth D. Ballard et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Hippocampal volume and the rapid antidepressant effect of ketamine
- (2014) Chadi G Abdallah et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic
- (2014) Peter R Diamond et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Akt Mediates GSK-3� Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
- (2014) Wei Zhou et al. NEUROIMMUNOMODULATION
- Baseline Vitamin B12 and Folate Levels Do Not Predict Improvement in Depression After a Single Infusion of Ketamine
- (2014) N. Lundin et al. PHARMACOPSYCHIATRY
- Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
- (2014) E. S. Gideons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
- (2014) Ruin Moaddel et al. PSYCHOPHARMACOLOGY
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression
- (2013) Mark J. Niciu et al. BIOLOGICAL PSYCHIATRY
- Neural correlates of rapid antidepressant response to ketamine in bipolar disorder
- (2013) Allison C Nugent et al. BIPOLAR DISORDERS
- Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder
- (2013) Mark J. Niciu et al. CNS SPECTRUMS
- DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID-ACTING ANTIDEPRESSANTS
- (2013) Mark J. Niciu et al. DEPRESSION AND ANXIETY
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
- (2013) C. N. Haile et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
- (2013) Diogo R. Lara et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting
- (2013) Chadi G. Abdallah et al. JOURNAL OF ECT
- Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression
- (2013) Kaija Järventausta et al. JOURNAL OF ECT
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Ketamine regulates the presynaptic release machinery in the hippocampus
- (2013) Heidi Kaastrup Müller et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive–compulsive disorder and a history of major depressive disorder
- (2013) Mark J Niciu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serial infusions of low-dose ketamine for major depression
- (2013) Keith G Rasmussen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
- (2013) Kihoon Han et al. NATURE
- 2012 FDA drug approvals
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
- (2013) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests
- (2013) Jesper T. Andreasen et al. NEUROSCIENCE LETTERS
- Vitamin B12 Level may be Related to the Efficacy of Single Ketamine Infusion in Bipolar Depression
- (2013) A. Permoda-Osip et al. PHARMACOPSYCHIATRY
- Intramuscular ketamine in acute depression: A report on two cases
- (2013) Chilukuri Harihar et al. Indian Journal of Psychiatry
- Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression
- (2012) Cristina Cusin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
- (2012) Gonzalo Laje et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- On the Safety and Benefits of Repeated Intravenous Injections of Ketamine For Depression
- (2012) Pierre Blier et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial
- (2012) Amit Anand et al. BIPOLAR DISORDERS
- Ketamine for Treatment-Resistant Unipolar Depression
- (2012) Sanjay J. Mathew et al. CNS DRUGS
- Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
- (2012) Janusz K. Rybakowski et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Suicide in the US Army
- (2012) Timothy W. Lineberry et al. MAYO CLINIC PROCEEDINGS
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
- (2012) Lobna Ibrahim et al. NEUROPSYCHOPHARMACOLOGY
- Neurocognitive Function and Schizophrenia-Proneness in Individuals Dependent on Ketamine, on High Potency Cannabis (‘Skunk’) or on Cocaine
- (2012) C.J. Morgan et al. PHARMACOPSYCHIATRY
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Next-Generation Treatments for Mental Disorders
- (2012) T. R. Insel Science Translational Medicine
- Dose- and Exposure-Response to Ketamine in Depression
- (2011) Paul Glue et al. BIOLOGICAL PSYCHIATRY
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
- (2011) Golam M.I. Chowdhury et al. BIOLOGICAL PSYCHIATRY
- Acute d-serine treatment produces antidepressant-like effects in rodents
- (2011) Oz Malkesman et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
- (2011) Gregory Luke Larkin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model
- (2011) M.-N. Quan et al. NEUROSCIENCE
- Overview of glutamatergic neurotransmission in the nervous system
- (2011) Mark J. Niciu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
- (2011) Gerald W. Valentine et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care
- (2010) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
- (2009) Celia J. A. Morgan et al. ADDICTION
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
- (2009) Gislaine Z. Réus et al. BRAIN RESEARCH BULLETIN
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
- (2009) Sanjay J. Mathew et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist
- (2009) Rodrigo Machado-Vieira et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
- (2009) M. Ghasemi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series
- (2009) G. Paslakis et al. PHARMACOPSYCHIATRY
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
- (2008) Celia J. A. Morgan et al. ADDICTION
- Correspondence
- (2008) AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N -methyl-D-aspartate Antagonist
- (2008) Laura E. Phelps et al. BIOLOGICAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Attentional bias to incentive stimuli in frequent ketamine users
- (2008) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started